RNS Number : 2125E
IMI PLC
13 September 2024
 

13 September 2024






IMI plc ("IMI" or the "Company")


Transaction in Own Shares






LEI: 2138002W9Q21PF751R30






IMI announces that on 13 September 2024 it purchased through Merrill Lynch International the following number of its ordinary shares for cancellation at an average price of 1,822.6911 pence per share:






Date of purchase:


13 September 2024

Number of ordinary shares purchased:

101,370

Highest purchase price paid per share:

1,827.00p

Lowest purchase price paid per share:

1,805.00p

Volume weighted average price paid per share:

1,822.69p






Following settlement of the above purchases and cancellation of the purchased ordinary shares, the Company's total number of ordinary shares in issue shall be 272,803,005. The Company holds 13,648,836 ordinary shares in treasury and therefore the total number of voting rights in the Company will be 259,154,169.






Aggregated Information

 





Date

Trading venue

Volume weighted average price (£ per share)

Number of Shares Purchased

13 September 2024

London Stock Exchange

18.23

76,000

13 September 2024

Chi-X (CXE)

18.21

16,858

13 September 2024

BATS (BXE)

18.20

4,853

13 September 2024

Turquoise

18.20

3,659






Transaction Details

 








In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it forms part of UK law, a full breakdown of the individual trades made by Merrill Lynch International on behalf of the Company as part of the Programme is detailed on the attached:






http://www.rns-pdf.londonstockexchange.com/rns/2125E_1-2024-9-13.pdf

 







Enquiries:










IMI plc





Louise Waldek, Company Secretary

0121 717 3700

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSQKNBBABKDCCD